Bortezomib Is Effective in the Treatment of T Lymphoblastic Leukaemia by Inducing DNA Damage, WEE1 Downregulation, and Mitotic Catastrophe.

Int J Mol Sci · 2023 · PMC10572992 · PMID 37834095

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The result showed that bortezomib increased the percentage of cells greater than the G2/M phase in a dose-dependent manner while the percentage of G0/G1 phase cells showed a trend of reduction with the increasing dose of bortezomib treatment, though statistical significance was not reached.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.